Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04150497
Title Phase I Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.

acute lymphoblastic leukemia



Age Groups: adult | senior
Covered Countries USA | FRA

No variant requirements are available.